Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1995-12-15
pubmed:abstractText
1. [3H]-lifarizine bound saturably and reversibly to an apparently homogeneous class of high affinity sites in rat cerebrocortical membranes (Kd = 10.7 +/- 2.9 nM; Bmax = 5.10 +/- 1.43 pmol mg-1 protein). 2. The binding of [3H]-lifarizine was unaffected by sodium channel toxins binding to site 1 (tetrodotoxin), site 3 (alpha-scorpion venom) or site 5 (brevetoxin), Furthermore, lifarizine at concentrations up to 10 microM had no effect on [3H]-saxitoxin (STX) binding to toxin site 1. Lifarizine displaced [3H]-batrachotoxinin-A 20-alpha-benzoate (BTX) binding with moderate affinity (pIC50 7.31 +/- 0.24) indicating an interaction with toxin site 2. However, lifarizine accelerated the dissociation of [3H]-BTX and decreased both the affinity and density of sites labelled by [3H]-BTX, suggesting an allosteric interaction with toxin site 2. 3. The binding of [3H]-lifarizine was voltage-sensitive, binding to membranes with higher affinity than to synaptosomes (pIC50 for cold lifarizine = 7.99 +/- 0.09 in membranes and 6.68 +/- 0.14 in synaptosomes). Depolarization of synaptosomes with 130 mM KCl increased the affinity of lifarizine almost 10 fold (pIC50 = 7.86 +/- 0.25). This suggests that lifarizine binds selectively to inactivated sodium channels which predominate both in the membrane preparation and in the depolarized synaptosomal preparation. 4. There was negligible [3H]-lifarizine and [3H]-BTX binding to solubilized sodium channels, although [3H]-STX binding was retained under these conditions. 5. The potencies of a series of compounds in displacing [3H]-lifarizine from rat cerebrocortical membranes correlated well with their affinities for inactivated sodium channels estimated from whole-cell voltage clamp studies in the mouse neuroblastoma cell line, NIE-115 (r=0.96).6. These results show that [3H]-lifarizine is a high affinity ligand for neuronal sodium channels which potently and selectively labels a site, allosterically linked to toxin binding site 2, associated within activated sodium channels.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-1336115, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-2006281, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-2413014, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-2426567, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-2433992, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-2436305, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-2446890, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-2773043, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-2844361, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-435456, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-500648, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-6114956, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-6247957, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-6262621, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-6270629, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-6270687, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-6281941, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-6286901, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-6319405, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-6321944, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-7516685, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-7599943, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-7606340, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-7922876, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-8085162, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-8388296, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582509-8391120
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
115
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1103-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
[3H]-lifarizine, a high affinity probe for inactivated sodium channels.
pubmed:affiliation
Department of Pharmacology, Syntex Research Centre, Heriot Watt University Research Park, Riccarton, Edinburgh.
pubmed:publicationType
Journal Article